Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Wendeler M et al. The enzyme-binding region of human GM2-activator protein. 2006 FEBS J. pmid:16478472
Kirvan CA et al. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. 2006 Autoimmunity pmid:16455579
Arfi A et al. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta. 2006 J. Neurochem. pmid:16441513
Ledeen RW and Wu G Gangliosides of the nuclear membrane: a crucial locus of cytoprotective modulation. 2006 J. Cell. Biochem. pmid:16408301
Jacques S et al. Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications. 2006 Org. Biomol. Chem. pmid:16358009
Sakuraba H et al. Molecular pathologies of and enzyme replacement therapies for lysosomal diseases. 2006 CNS Neurol Disord Drug Targets pmid:16918392
Fuse T et al. Synthesis and enzymatic susceptibility of a series of novel GM2 analogs. 2006 Glycoconj. J. pmid:16897176
Itakura T et al. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. 2006 Biol. Pharm. Bull. pmid:16880605
Crawley AC et al. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. 2006 Brain Res. pmid:16828069
Biswas K et al. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction. 2006 Cancer Res. pmid:16818659
Thiesen PH et al. Glycolipids from a colloid chemical point of view. 2006 J. Biotechnol. pmid:16707183
Bruce AF et al. Functional characterisation of a nematode secreted GM2-activator protein. 2006 Mol. Biochem. Parasitol. pmid:16569450
Yin J et al. Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. 2006 Cancer Res. pmid:16540641
Ragupathi G et al. Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates. 2006 J. Am. Chem. Soc. pmid:16492059
Sango K et al. Impaired neurite outgrowth in the retina of a murine model of Sandhoff disease. 2005 Invest. Ophthalmol. Vis. Sci. pmid:16123447
Tsuji D et al. Metabolic correction in microglia derived from Sandhoff disease model mice. 2005 J. Neurochem. pmid:16092933
Schwarzmann G et al. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system. 2005 Glycobiology pmid:16079415
Retter MW et al. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. 2005 Cancer Res. pmid:16024647
Blixt O et al. Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a. 2005 Carbohydr. Res. pmid:16005859
Arfi A et al. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts. 2005 Neurobiol. Dis. pmid:15953731